Drug Database
Back to search

Belgium· BE-AMP-SAM447155-00

Moxifloxacine Fresenius Kabi 400 mg/250 ml

A moxifloxacin product containing moxifloxacin hydrochloride, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 16 of our 19 countries.

ATC J01MA14

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMoxifloxacine Fresenius Kabi 400 mg/2…ATCJ01MA14REGISTER NO.BE-AMP-SAM447155-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about moxifloxacin hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Moxifloxacin is registered in 16 of 19 countries.

Countries holding a registration under ATC J01MA14 (moxifloxacin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search moxifloxacin products by name

Moxifloxacin · ATC J01MA14

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxifloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.34 in United States to $6.89 in Switzerland — a ×5.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Moxifloxacin · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.89
  • IT Italy$1.99
  • US United States$1.34 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Moxifloxacin Hydrochloride
Manufacturer
Fresenius Kabi
Country
Belgium (BE)
ATC code
J01MA14
ATC class
Moxifloxacin
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    3589777
  • be_apb
    7720162

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

531 interactions on record for moxifloxacin.

Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check moxifloxacin against other medicinesHow interaction checks work

Moxifloxacin · interactions on record

531 records

  • 175 severe
  • 140 moderate
  • 49 minor
  • 92 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

75 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Moxifloxacin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxifloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Avelox, Moxifloxacin 1a Pharma
  • Bulgaria · Cimocinox, Moxifloxacin Kabi
  • Cyprus · Avelox, Erelan
  • Czechia · Avelox, Moxifloxacin Brown & Burk
  • Germany · Avalox, Moxifloxacin 1 A Pharma
  • Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
  • Estonia · Avelox, Floxelan
  • Spain · Abimox, Actira
  • Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
  • France · Izilox, Moxifloxacine Arrow
  • United Kingdom (Northern Ireland) · Avelox, Moxidox
  • Greece · Avelox, Mikrobiel
  • Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
  • Hungary · Moxibiot, Moxifloxacin Anfarm
  • Ireland · Moxifloxacin
  • Iceland · Vigamox
  • Italy · Avalox, Moxidrop
  • Lithuania · Avelox, Ekara
  • Luxembourg · Avelox, Kanavig
  • Latvia · Avelox, Ekara
  • Malta · Erelan, Moxifloxacin Anfarm
  • Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
  • Norway · Xinaflox
  • Poland · Flomixa, Floxamic Neo
  • Portugal · Avelox, Bluesar
  • Romania · Avelox, Kimoks
  • Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
  • Slovenia · Kimoks, Moksifloksacin Kabi
  • Slovakia · Avelox, Moloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/edabc624-aac2-496e-9570-c3677b1d7af5
GET /v1/drugs/edabc624-aac2-496e-9570-c3677b1d7af5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Moxifloxacine Fresenius Kabi 400 mg/250 ml",
  "name_fr": "Moxifloxacine Fresenius Kabi 400 mg/250 ml",
  "name_nl": "Moxifloxacine Fresenius Kabi 400 mg/250 ml",
  "amp_code": "SAM447155-00",
  "strengths": [
    "437.5000",
    "400.0000",
    "1700.0000",
    "2840.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Moxifloxacin Hydrochloride",
    "Moxifloxacin",
    "Sodium Acetate Trihydrate",
    "Sodium Sulfate Anhydrous"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Moxifloxacin",
  "authorisation_numbers": [
    "BE447155"
  ]
}
API referenceMCP serverPlans

See everything about moxifloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console